Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 6Peritoneal Neoplasms 6Ovarian Neoplasms 4Neoplasm Metastasis 4Colorectal Neoplasms 3Pancreatic Neoplasms 2Neoplasms 2Gastric Adenocarcinoma 2Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Appendiceal Neoplasms 2Uterine Neoplasms 1Stomach Diseases 1Pseudomyxoma Peritonei 1Ovarian Epithelial Cancer Recurrent 1Locally Advanced Gastric Cancer 1Krukenberg Tumor 1HIPEC 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Gastric Cancer Peritoneal Metastases 1Digestive System Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1

Interventions

S 1 (combination) 1Oxaliplatin 1Hyperthermic Intraperitoneal Chemotherapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Gastric Cancer × Hyperthermic Intraperitoneal Chemotherapy × 1 year × Clear all
NCT07621484 2026-06-02

HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer

Shanghai Changzheng Hospital

Phase 2 Not yet recruiting
48 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡